Condition Lookup

Emphysema

Sub-category: Chronic Obstructive Pulmonary Disease (COPD)

Symptoms:
shortness of breath (dyspnea); chronic cough (often dry); wheezing; fatigue; barrel-shaped chest; weight loss; reduced exercise tolerance

Root Cause:
Destruction of alveolar walls and loss of elastic recoil in the lungs due to chronic exposure to irritants like smoking. This results in air trapping, hyperinflation of the lungs, and impaired gas exchange.

How it's Diagnosed: videos
Clinical history, spirometry (showing reduced FEV1/FVC ratio), chest X-ray (showing hyperinflated lungs and flattened diaphragms), CT scan (for visualization of emphysematous changes), and blood gas analysis in severe cases.

Treatment:
Smoking cessation, pulmonary rehabilitation, bronchodilators, corticosteroids (inhaled or oral), long-term oxygen therapy for advanced cases, and surgical options like lung volume reduction surgery or lung transplant in severe cases.

Medications:
Inhaled bronchodilators (e.g., albuterol - a short-acting beta-agonist, salmeterol - a long-acting beta-agonist); anticholinergics (e.g., ipratropium ); combination inhalers (e.g., budesonide /formoterol ); inhaled corticosteroids (e.g., fluticasone ); and phosphodiesterase-4 inhibitors (e.g., roflumilast ).

Prevalence: How common the health condition is within a specific population.
Emphysema affects approximately 5%–6% of the adult population globally, with higher prevalence among smokers and individuals over 40.

Risk Factors: Factors or behaviors that increase the likelihood of developing the condition.
Cigarette smoking (most significant factor), exposure to air pollutants, occupational exposure to dust and chemicals, recurrent respiratory infections, and alpha-1 antitrypsin deficiency.

Prognosis: The expected outcome or course of the condition over time.
Progressive disease with no cure. Smoking cessation and proper treatment slow progression and improve quality of life. Advanced disease often leads to disability and reduced life expectancy.

Complications: Additional problems or conditions that may arise as a result of the original condition.
Pulmonary hypertension, right-sided heart failure (cor pulmonale), pneumothorax (collapsed lung), frequent exacerbations, and respiratory failure in advanced stages.

Non-Allergic Asthma

Specialty: Pulmonology

Category: Obstructive Lung Diseases

Sub-category: Asthma

Symptoms:
wheezing; shortness of breath; chest tightness; persistent coughing (not linked to allergens); symptoms worsen with exposure to irritants like smoke, cold air, or strong odors

Root Cause:
Airway inflammation and hyperresponsiveness triggered by non-allergic factors (e.g., infections, environmental irritants, stress, or exercise).

How it's Diagnosed: videos
Medical history, physical exam, pulmonary function tests (spirometry), and exclusion of allergic causes through skin or blood tests.

Treatment:
Inhaled corticosteroids, bronchodilators, leukotriene receptor antagonists, and avoidance of irritants.

Medications:
Inhaled corticosteroids (e.g., mometasone , beclomethasone ) to manage chronic inflammation; bronchodilators like long-acting beta-agonists (e.g., salmeterol ) or short-acting beta-agonists (e.g., albuterol ) for symptom relief; and leukotriene receptor antagonists (e.g., montelukast ) to reduce inflammation. Biologic therapies (e.g., mepolizumab ) may be used in severe cases.

Prevalence: How common the health condition is within a specific population.
Less common than allergic asthma; typically develops in adults, especially women.

Risk Factors: Factors or behaviors that increase the likelihood of developing the condition.
Respiratory infections, occupational exposure to irritants, obesity, smoking, and air pollution.

Prognosis: The expected outcome or course of the condition over time.
Manageable with treatment; avoiding triggers is crucial for symptom control.

Complications: Additional problems or conditions that may arise as a result of the original condition.
Severe asthma exacerbations, airway remodeling, and increased risk of infections or bronchiectasis.

Exercise-Induced Asthma (EIA)

Specialty: Pulmonology

Category: Obstructive Lung Diseases

Sub-category: Asthma

Symptoms:
shortness of breath; wheezing; coughing (post-exercise); chest tightness; decreased exercise tolerance; fatigue during or after exercise

Root Cause:
Temporary airway narrowing triggered by physical activity, often due to rapid breathing of dry or cold air causing airway dehydration and inflammation.

How it's Diagnosed: videos
Exercise challenge test (spirometry before and after exercise), eucapnic voluntary hyperpnea (EVH) test, or observation of symptom patterns during exercise.

Treatment:
Pre-exercise use of bronchodilators, maintenance inhaled corticosteroids if symptoms are frequent, warm-up exercises, and avoiding exercise in cold or dry conditions.

Medications:
Short-acting beta-agonists (e.g., albuterol ) for immediate relief before exercise; inhaled corticosteroids (e.g., fluticasone ) for chronic symptom control; leukotriene receptor antagonists (e.g., montelukast ) to reduce exercise-induced inflammation.

Prevalence: How common the health condition is within a specific population.
Affects up to 10% of the general population and 90% of people with existing asthma.

Risk Factors: Factors or behaviors that increase the likelihood of developing the condition.
Underlying asthma, cold weather, dry air, high-intensity exercise, and poor physical conditioning.

Prognosis: The expected outcome or course of the condition over time.
Excellent with proper treatment and prevention strategies; most people can maintain an active lifestyle.

Complications: Additional problems or conditions that may arise as a result of the original condition.
Severe exercise limitations, poor physical fitness, and risk of exacerbation of underlying asthma.

Bronchiectasis

Specialty: Pulmonology

Category: Obstructive Lung Diseases

Symptoms:
chronic cough; excessive mucus production; shortness of breath; recurrent respiratory infections; wheezing; fatigue; chest pain

Root Cause:
Permanent dilation and damage of the bronchial tubes due to chronic inflammation and infection, leading to impaired mucus clearance.

How it's Diagnosed: videos
Diagnosis is made using chest CT scans (to visualize bronchial dilation), pulmonary function tests, sputum analysis for infections, and blood tests to check for underlying conditions.

Treatment:
Treatment includes airway clearance techniques, pulmonary rehabilitation, antibiotics for infections, and management of underlying conditions.

Medications:
Antibiotics (e.g., azithromycin , ciprofloxacin , or amoxicillin-clavulanate) for bacterial infections; bronchodilators (e.g., albuterol , salmeterol ) to ease breathing; inhaled corticosteroids (e.g., budesonide , fluticasone ) to reduce airway inflammation; and mucolytics (e.g., hypertonic saline, dornase alfa) to thin mucus.

Prevalence: How common the health condition is within a specific population.
Estimated to affect 350,000–500,000 people in the United States, with higher prevalence in older adults and those with underlying conditions.

Risk Factors: Factors or behaviors that increase the likelihood of developing the condition.
Previous lung infections (e.g., tuberculosis, pneumonia), genetic conditions (e.g., cystic fibrosis), immune system disorders, chronic aspiration, and smoking.

Prognosis: The expected outcome or course of the condition over time.
With proper treatment, symptoms can be managed, and quality of life can improve, but the condition is chronic and progressive without a cure.

Complications: Additional problems or conditions that may arise as a result of the original condition.
Recurrent lung infections, respiratory failure, hemoptysis (coughing up blood), pulmonary hypertension, and reduced quality of life.

Obliterative Bronchiolitis (Bronchiolitis Obliterans)

Specialty: Pulmonology

Category: Obstructive Lung Diseases

Sub-category: Small Airway Diseases

Symptoms:
chronic cough; shortness of breath; wheezing; fatigue; exercise intolerance

Root Cause:
Inflammation and scarring (fibrosis) of the small airways (bronchioles), leading to airflow obstruction.

How it's Diagnosed: videos
Diagnosis involves a combination of clinical history, physical examination, pulmonary function tests (showing obstructive patterns), high-resolution CT scans (showing mosaic attenuation), and, in some cases, lung biopsy for definitive diagnosis.

Treatment:
Management includes supportive care, removal of causative agents, medications to reduce inflammation, and, in severe cases, lung transplantation.

Medications:
Corticosteroids (e.g., prednisone ) to reduce inflammation, immunosuppressive drugs like mycophenolate mofetil or azathioprine to slow disease progression, and macrolide antibiotics such as azithromycin for anti-inflammatory effects. Bronchodilators like albuterol may be used for symptom relief.

Prevalence: How common the health condition is within a specific population.
Rare, with prevalence varying based on underlying causes (e.g., post-lung transplantation, inhalational exposure to toxic fumes).

Risk Factors: Factors or behaviors that increase the likelihood of developing the condition.
Lung transplantation, hematopoietic stem cell transplantation, exposure to toxic fumes (e.g., diacetyl in popcorn factories), autoimmune diseases, and viral infections.

Prognosis: The expected outcome or course of the condition over time.
Chronic and progressive; prognosis depends on the underlying cause and response to treatment. Lung transplantation may improve survival in severe cases.

Complications: Additional problems or conditions that may arise as a result of the original condition.
Progressive respiratory failure, pulmonary hypertension, secondary infections, and reduced quality of life due to persistent symptoms.